Literature DB >> 2624263

Partial deletion of 14q and partial duplication of 14q in sibs: testicular mosaicism for t(14q;14q) as a common mechanism.

C T Masada1, A H Olney, R Fordyce, W G Sanger.   

Abstract

The propositus and a subsequently born sister presented with multiple congenital anomalies. Chromosome analyses were performed initially on peripheral blood lymphocytes from the propositus and his parents: the propositus was found to have a deletion of chromosome 14 (q32.11- greater than qter); the parents' chromosomes were normal. When the sister of the propositus was born, she was determined to have a duplication of an equivalent segment of 14qter. Chromosome studies on the parents' fibroblasts demonstrated no structural abnormality or mosaicism. The parents have an older, phenotypically normal, healthy daughter, which supports mosaicism for intragonadal t(14;14)(q32.11;q32.33) in one parent. Chromosome polymorphism comparisons show that the normal number 14 chromosome in the propositus and his sister was inherited from the mother, thus indicating paternal testicular mosaicism. Clinical findings are compared to those of other reported cases of deletion 14q and duplication 14q.

Entities:  

Mesh:

Year:  1989        PMID: 2624263     DOI: 10.1002/ajmg.1320340415

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy.

Authors:  T Grimm; B Müller; C R Müller; M Janka
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

2.  Recurrent 70.8 Mb 4q22.2q32.3 duplication due to ovarian germinal mosaicism.

Authors:  Lucie Tosca; Sophie Brisset; François M Petit; Laure Lecerf; Ghislaine Rousseau; Cécile Bas; Mireille Laroudie; Marie-Laure Maurin; Sylvie Tapia; Olivier Picone; Sophie Prevot; Michel Goossens; Philippe Labrune; Gérard Tachdjian
Journal:  Eur J Hum Genet       Date:  2010-04-28       Impact factor: 4.246

3.  Mosaicism with a normal cell line and an autosomal structural rearrangement.

Authors:  R J Gardner; H E Dockery; P H Fitzgerald; R G Parfitt; D R Romain; N Scobie; R L Shaw; P Tumewu; A J Watt
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

Review 4.  Genetic factors in congenital diaphragmatic hernia.

Authors:  A M Holder; M Klaassens; D Tibboel; A de Klein; B Lee; D A Scott
Journal:  Am J Hum Genet       Date:  2007-04-04       Impact factor: 11.025

5.  Array CGH defined interstitial deletion on chromosome 14: a new case.

Authors:  Maria Piccione; Vincenzo Antona; Valeria Scavone; Michela Malacarne; Mauro Pierluigi; Marina Grasso; Giovanni Corsello
Journal:  Eur J Pediatr       Date:  2010-01-21       Impact factor: 3.183

6.  Molecular analysis redefines three human chromosome 14 deletions.

Authors:  R F Wintle; T Costa; R H Haslam; I E Teshima; D W Cox
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

7.  Parental origin effects in human trisomy for chromosome 14q: implications for genomic imprinting.

Authors:  P Georgiades; C Chierakul; A C Ferguson-Smith
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

Review 8.  Somatic/gonadal mosaicism for structural autosomal rearrangements: female predominance among carriers of gonadal mosaicism for unbalanced rearrangements.

Authors:  Natalia V Kovaleva; Philip D Cotter
Journal:  Mol Cytogenet       Date:  2016-01-28       Impact factor: 2.009

9.  14q32.3-qter trisomic segment: a case report and literature review.

Authors:  Nicoletta Villa; Agnese Scatigno; Serena Redaelli; Donatella Conconi; Paola Cianci; Clotilde Farina; Chiara Fossati; Leda Dalprà; Silvia Maitz; Angelo Selicorni
Journal:  Mol Cytogenet       Date:  2016-08-05       Impact factor: 2.009

Review 10.  A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review.

Authors:  Ji Yoon Han; Joonhong Park
Journal:  Genes (Basel)       Date:  2021-09-07       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.